Muromonab CD3 (Orthoclone OKT3) for the prophylaxis of heart allograft rejection. Hemodynamics and respiratory tolerance

Treatment of transplant rejection with muromonab CD3 (Orthoclone OKT3) may result in haemodynamic instability and pulmonary oedema, which would question its prophylactic use. The aim of this study was to the evaluate haemodynamic and respiratory tolerance of prophylactic treatment of cardiac rejecti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annales françaises d'anesthésie et de réanimation 1995, Vol.14 (4), p.331
Hauptverfasser:	Guinvarc'h, A, Fouillard, A, Amrein, C, Guillemain, R, Chevalier, P, Acar, C, Couetil, J P, Vulser, C
Format:	Artikel
Sprache:	fre
Schlagworte:	Adult Female Graft Rejection - prevention & control Heart Transplantation - adverse effects Hemodynamics - drug effects Humans Immunosuppressive Agents - pharmacology Male Middle Aged Muromonab-CD3 - pharmacology Prospective Studies Respiration - drug effects Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!